The available evidence does not show large differences in stroke prevention between antihypertensive drugs—therefore, other factors such as protection against other forms of cardiovascular disease and cost should be considered.
Dostupni dokazi ne pokazuju značajne razlike između antihipertenzivnih lijekova – stoga, treba uzeti u obzir i druge čimbenike kao što su zaštita od drugih oblika kardiovaskularnih bolesti i troškovi.